BioTissue Holdings, Inc.
Explore this company’s associated devices, FDA decisions and regulatory history.

BioTissue Holdings, Inc.
- Regulatory records
- 1
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 1 FDA record to the applicant name BioTissue Holdings, Inc.. The collection includes 1 510(k) clearance. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Jun 5, 2026 to Jun 5, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code KGN appears in 1 of the 1 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 7300 Corporate Center Dr., Suite 700, Miami, FL, 33126, US. Recorded on K253204, decision dated Jun 5, 2026.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
Catalyze
K253204 · 510(k) clearance
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.